Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000352

Drug Information
NameOSI-930
Synonyms3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide; 728033-96-3; OSI 930; S1220_Selleck; CID9868037; OSI930; OSI-930; OSI-930 is a multi-targeted tyrosine kinase inhibitor
CompanyOSI Pharmaceuticals
IndicationVarious cancers
[ICD9: 140-229   ICD10: C00-C96]
Phase I    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C22H16F3N3O2S/c23-22(24,25)30-16-7-5-15(6-8-16)28-21(29)20-19(
10-12-31-20)27-13-14-9-11-26-18-4-2-1-3-17(14)18/h1-12,27H,13H2,(
H,28,29)
InChIKeyFGTCROZDHDSNIO-UHFFFAOYSA-N
Canonical SMILESC1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F    
Therapeutic ClassAntineoplastic Agents
FormulaC22H16F3N3O2S
PubChem Compound IDCID 9868037.
PubChem Substance IDSID 14832924.
ClinicalTrials.govNCT00513851;
TargetMast/stem cell growth factor receptorInhibitor[1]
Mast/stem cell growth factor receptorMultitarget[1]
Vascular endothelial growth factor receptor 2Inhibitor[1]
Vascular endothelial growth factor receptor 2Multitarget[1]
Ref 1A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development. Curr Top Med Chem. 2007;7(14):1408-22. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543